Lactobacillus rhamnosus GG and Reduced Antimicrobial-Resistant Organism Infection

• A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization.

  • 2021-04-06
  • RCT · n = 44
  • Infection control and hospital epidemiology 43(2)
  • • Adriana M Rauseo
    • Tiffany Hink
    • Kimberly A Reske
    • Sondra M Seiler
    • Kerry M Bommarito
    • Victoria J Fraser
    • Carey-Ann D Burnham
    • Erik R Dubberke

  • PubMed: 33820576
  • DOI: 10.1017/ice.2021.94

  8 Insights on

  • Reduced Antimicrobial-Resistant Organism Infection

  • High evidence
  • Clinical

  We detected no difference in any ARO acquisition (LGG 30% vs placebo 33%; OR,1.19; 95% CI, 0.38-3.75)

  Effect

  Neutral

  Effect size

  Small

  Significant

  No

  Dose

  2×10^10 cells per day